Cowealth Medical China Co.Ltd. Capital Reinvestment Ratio

Latest as of December 2025: 0.80x

Cowealth Medical China Co.Ltd. capital reinvestment ratio. Cowealth Medical China Co.Ltd. (603122) has a Capital Reinvestment Ratio of 0.80x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥17.68 Million) in capital expenditures (CN¥14.21 Million). See how much free cash does Cowealth Medical China Co.Ltd. generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.80x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥17.68 Million
CNY

Capital Expenditures

CN¥14.21 Million
CNY

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Cowealth Medical China Co.Ltd. (2020–2025)

Capital reinvestment ratio of Cowealth Medical China Co.Ltd. from 2020 to 2025. This chart tracks Cowealth Medical China Co.Ltd.'s Capital Reinvestment Ratio across 5 annual periods. See how financially flexible is Cowealth Medical China Co.Ltd. to measure the company's free cash flow as a share of total liabilities.

Cowealth Medical China Co.Ltd. Capital Reinvestment Ratio by Year (2020–2025)

Cowealth Medical China Co.Ltd. capital reinvestment ratio by year from 2020 to 2025. For the full cash flow conversion analysis, see 603122 operating cash flow.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.80x CN¥17.68 Million CN¥14.21 Million ▲ +235.2%
2024 0.24x CN¥132.75 Million CN¥31.82 Million ▼ -96.0%
2023 6.02x CN¥11.28 Million CN¥67.96 Million ▲ +90.9%
2021 3.16x CN¥7.01 Million CN¥22.12 Million ▲ +2785.6%
2020 0.11x CN¥74.15 Million CN¥8.11 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow